Effect of lactoferrin treatment on symptoms and physical performance in long COVID patients: a randomised, double-blind, placebo-controlled trial.

Anne-Lotte RedelFatana MiryMerel Elise HellemonsLaurien Maria Amarentia OswaldGerrit Johannes Braunstahl

Published in: ERJ open research (2024)

Although both long COVID arms showed improved clinical outcomes at T6, the improvement did not continue until T12. Lactoferrin provided no benefit in terms of fatigue, other patient-reported outcome measures or physical functioning.

Keyphrases

double blind
patient reported
placebo controlled
sars cov
clinical trial
physical activity
study protocol
mental health
coronavirus disease
sleep quality
open label
phase iii
recombinant human
phase ii
randomized controlled trial
respiratory syndrome coronavirus
combination therapy